Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports

After President Trump on Thursday implied a decades-old malaria drug was sanctioned by the FDA to fight the new coronavirus, reports emerged that late last year the drug’s maker doubled the price of the compound, but has now restored the original price tag as the virus envelops much of the globe.